Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology

References

• Brown MA, Stenberg LM, Mauk AG. Identification of catalytically important amino acids in human ceruloplasmin by site-directed mutagenesis. FEBS Lett. 2002;520(1–3):8–12. doi:10.1016/S0014-5793(02)02652-2
   Web of Science ®Google Scholar
• Linder MC. Ceruloplasmin and other copper binding components of blood plasma and their functions: an update. Metallomics. 2016;8(9):887–905. doi:10.1039/C6MT00103C
   PubMed Web of Science ®Google Scholar
• Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol. 2006;13(3):142–148. doi:10.1016/j.spen.2006.08.002
   Google Scholar
• Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439–458. doi:10.1146/annurev.nutr.22.012502.114457
   PubMed Web of Science ®Google Scholar
• Kirsipuu T, Zadorožnaja A, Smirnova J, et al. Copper (II)-binding equilibria in human blood. Sci Rep. 2020;10(1):5686. doi:10.1038/s41598-020-62560-4
   Web of Science ®Google Scholar
• Chapman AL, Mocatta TJ, Shiva S, et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem. 2013;288(9):6465–6477. doi:10.1074/jbc.M112.418970
   PubMed Web of Science ®Google Scholar
• Golizeh M, Lee K, Ilchenko S, et al. Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes. Free Radic Biol Med. 2017;113:461–469. doi:10.1016/j.freeradbiomed.2017.10.373
   Web of Science ®Google Scholar
• Kim OY, Shin MJ, Moon J, Chung JH. Plasma ceruloplasmin as a biomarker for obesity: a proteomic approach. Clin Biochem. 2011;44(5–6):351–356. doi:10.1016/j.clinbiochem.2011.01.014
   Web of Science ®Google Scholar
• Daimon M, Yamatani K, Igarashi M, et al. Fine structure of the human ceruloplasmin gene. Biochem Biophys Res Commun. 1995;208(3):1028–1035. doi:10.1006/bbrc.1995.1437
   PubMed Web of Science ®Google Scholar
• Yang F, Naylor SL, Lum JB, et al. Characterization, mapping, and expression of the human ceruloplasmin gene. Proc Natl Acad Sci U S A. 1986;83(10):3257–3261. doi:10.1073/pnas.83.10.3257
   Web of Science ®Google Scholar
• Bento I, Peixoto C, Zaitsev VN, Lindley PF. Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites. Acta Crystallogr D Biol Crystallogr. 2007;63(Pt 2):240–248. doi:10.1107/S090744490604947X
   PubMedGoogle Scholar
• Bakhautdin B, Goksoy Bakhautdin E, Fox PL. Ceruloplasmin has two nearly identical sites that bind myeloperoxidase. Biochem Biophys Res Commun. 2014;453(4):722–727. doi:10.1016/j.bbrc.2014.09.134
   Web of Science ®Google Scholar
• Samygina VR, Sokolov AV, Bourenkov G, et al. Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins. PLoS One. 2013;8(7):e67145. doi:10.1371/journal.pone.0067145
   Web of Science ®Google Scholar
• Mukhopadhyay BP. Insights from molecular dynamics simulation of human ceruloplasmin (ferroxidase enzyme) binding with biogenic monoamines. Bioinformation. 2019;15(10):750–759. doi:10.6026/97320630015750
   PubMed Web of Science ®Google Scholar
• Terada K, Kawarada Y, Miura N, Yasui O, Koyama K, Sugiyama T. Copper incorporation into ceruloplasmin in rat livers. Biochim Biophys Acta. 1995;1270(1):58–62. doi:10.1016/0925-4439(94)00072-X
   Web of Science ®Google Scholar
• Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, De Jong GJ, Gitlin JD. Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem. 2002;277(48):46632–46638. doi:10.1074/jbc.M206246200
   Web of Science ®Google Scholar
• Ramos D, Mar D, Ishida M, et al. Mechanism of copper uptake from blood plasma ceruloplasmin by mammalian cells. PLoS One. 2016;11(3):e0149516. doi:10.1371/journal.pone.0149516
   PubMed Web of Science ®Google Scholar
• Marques L, Auriac A, Willemetz A, et al. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface. Blood Cells Mol Dis. 2012;48(2):110–120. doi:10.1016/j.bcmd.2011.11.005
   Web of Science ®Google Scholar
• Banha J, Marques L, Oliveira R, et al. Ceruloplasmin expression by human peripheral blood lymphocytes: a new link between immunity and iron metabolism. Free Radic Biol Med. 2008;44(3):483–492.
   Web of Science ®Google Scholar
• Arner E, Forrest AR, Ehrlund A, et al. Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS One. 2014;9(3):e80274. doi:10.1371/journal.pone.0080274
   Web of Science ®Google Scholar
• Patel BN, David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem. 1997;272(32):20185–20190. doi:10.1074/jbc.272.32.20185
   Web of Science ®Google Scholar
• Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem. 2000;275(6):4305–4310. doi:10.1074/jbc.275.6.4305
   Web of Science ®Google Scholar
• Ryan F, Zarruk JG, Lößlein L, David S. Ceruloplasmin plays a neuroprotective role in cerebral ischemia. Front Neurosci. 2018;12:988. doi:10.3389/fnins.2018.00988
   PubMed Web of Science ®Google Scholar
• Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278(29):27144–27148. doi:10.1074/jbc.M301988200
   PubMed Web of Science ®Google Scholar
• Capo CR, Arciello M, Squitti R, et al. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer’s disease patients. Biometals. 2008;21(3):367–372. doi:10.1007/s10534-007-9125-4
   Web of Science ®Google Scholar
• Squitti R, Quattrocchi CC, Salustri C, Rossini PM. Ceruloplasmin fragmentation is implicated in “free” copper deregulation of Alzheimer’s disease. Prion. 2008;2(1):23–27. doi:10.4161/pri.2.1.6297
   PubMed Web of Science ®Google Scholar
• Squitti R, Quattrocchi CC, Forno GD, et al. Ceruloplasmin (2-D PAGE) pattern and copper content in serum and brain of Alzheimer disease patients. Biomark Insights. 2007;1:205–213.
   Google Scholar
• Siotto M, Simonelli I, Pasqualetti P, et al. Association between serum ceruloplasmin specific activity and risk of Alzheimer's disease. J Alzheimers Dis. 2016;50(4):1181–1189. doi:10.3233/JAD-150611
   Web of Science ®Google Scholar
• Mostad EJ, Prohaska JR. Glycosylphosphatidylinositol-linked ceruloplasmin is expressed in multiple rodent organs and is lower following dietary copper deficiency. Exp Biol Med (Maywood). 2011;236(3):298–308. doi:10.1258/ebm.2010.010256
   PubMed Web of Science ®Google Scholar
• Broderius MA, Prohaska JR. Differential impact of copper deficiency in rats on blood cuproproteins. Nutr Res. 2009;29(7):494–502. doi:10.1016/j.nutres.2009.06.006
   Web of Science ®Google Scholar
• Broderius M, Mostad E, Wendroth K, Prohaska JR. Levels of plasma ceruloplasmin protein are markedly lower following dietary copper deficiency in rodents. Comp Biochem Physiol C Toxicol Pharmacol. 2010;151(4):473–479. doi:10.1016/j.cbpc.2010.02.005
   Web of Science ®Google Scholar
• Vasilyev VB. Interactions of caeruloplasmin with other proteins participating in inflammation. Biochem Soc Trans. 2010;38(4):947–951. doi:10.1042/BST0380947
   Web of Science ®Google Scholar
• Golenkina EA, Viryasova GM, Galkina SI, Gaponova TV, Sud’ina GF, Sokolov AV. Fine regulation of neutrophil oxidative status and apoptosis by ceruloplasmin and its derivatives. Cells. 2018;7(1). doi:10.3390/cells7010008
   Web of Science ®Google Scholar
• Sokolov AV, Pulina MO, Ageeva KV, et al. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase. Biochemistry (Mosc). 2007;72(4):409–415. doi:10.1134/S0006297907040074
   Web of Science ®Google Scholar
• Ganaraja B, Pavithran P, Ghosh S. Effect of estrogen on plasma ceruloplasmin level in rats exposed to acute stress. Indian J Med Sci. 2004;58(4):150–154.
   Google Scholar
• Guller S, Buhimschi CS, Ma YY, et al. Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia. Lab Invest. 2008;88(10):1057–1067. doi:10.1038/labinvest.2008.74
   Web of Science ®Google Scholar
• Dey M, Arora D, Narayan N, Kumar R. Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre-eclampsia. N Am J Med Sci. 2013;5(1):41–46. doi:10.4103/1947-2714.106198
   PubMedGoogle Scholar
• Mukhopadhyay BP. Putative role of conserved water molecules in the hydration and inter-domain recognition of mono nuclear copper centers in O2-bound human ceruloplasmin: a comparative study between X-ray and MD simulated structures. Bioinformation. 2019;15(6):402–411. doi:10.6026/97320630015402
   Web of Science ®Google Scholar
• Haberska K, Vaz-Domínguez C, De Lacey AL, Dagys M, Reimann CT, Shleev S. Direct electron transfer reactions between human ceruloplasmin and electrodes. Bioelectrochemistry. 2009;76(1–2):34–41. doi:10.1016/j.bioelechem.2009.05.012
   Web of Science ®Google Scholar
• Stoj C, Kosman DJ. Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: implication for function. FEBS Lett. 2003;554(3):422–426. doi:10.1016/S0014-5793(03)01218-3
   Web of Science ®Google Scholar
• Musci G, Bonaccorsi di Patti MC, Calabrese L. Modulation of the redox state of the copper sites of human ceruloplasmin by chloride. J Protein Chem. 1995;14(7):611–619. doi:10.1007/BF01886887
   Google Scholar
• Tian S, Jones SM, Jose A, Solomon EI. Chloride control of the mechanism of human serum ceruloplasmin (Cp) catalysis. J Am Chem Soc. 2019;141(27):10736–10743. doi:10.1021/jacs.9b03661
   Web of Science ®Google Scholar
• Saenko EL, Siverina OB, Basevich VV, Yaropolov AI. Study of ceruloplasmin oxidase activity. The effect of pH. Biochem Int. 1990;20(6):1049–1058.
   Google Scholar
• Gulec S, Collins JF. Molecular mediators governing iron-copper interactions. Annu Rev Nutr. 2014;34:95–116. doi:10.1146/annurev-nutr-071812-161215
   Web of Science ®Google Scholar
• Arredondo M, Muñoz P, Mura CV, Nùñez MT. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am J Physiol Cell Physiol. 2003;284(6):C1525–1530. doi:10.1152/ajpcell.00480.2002
   Web of Science ®Google Scholar
• Zheng Y, Li XK, Wang Y, Cai L. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin. 2008;32(1–2):135–145. doi:10.1080/03630260701727077
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Wang F. Essential but toxic: controlling the flux of iron in the body. Clin Exp Pharmacol Physiol. 2012;39(8):719–724. doi:10.1111/j.1440-1681.2011.05661.x
   Web of Science ®Google Scholar
• Tennant J, Stansfield M, Yamaji S, Srai SK, Sharp P. Effects of copper on the expression of metal transporters in human intestinal Caco-2 cells. FEBS Lett. 2002;527(1–3):239–244. doi:10.1016/S0014-5793(02)03253-2
   Web of Science ®Google Scholar
• Zheng G, Zhang J, Xu Y, et al. Involvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cells. Toxicol Lett. 2014;225(1):110–118. doi:10.1016/j.toxlet.2013.11.034
   Web of Science ®Google Scholar
• Moriya M, Ho YH, Grana A, et al. Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism. Am J Physiol Cell Physiol. 2008;295(3):C708–721. doi:10.1152/ajpcell.00029.2008
   Web of Science ®Google Scholar
• Gulec S, Anderson GJ, Collins JF. Mechanistic and regulatory aspects of intestinal iron absorption. Am J Physiol Gastrointest Liver Physiol. 2014;307(4):G397–409. doi:10.1152/ajpgi.00348.2013
   PubMed Web of Science ®Google Scholar
• Lenartowicz M, Krzeptowski W. [Structure and function of ATP7A and ATP7B proteins–Cu-transporting ATPases]. Postepy Biochem. 2010;56(3):317–327. Polish.
   Google Scholar
• de Romaña DL, Olivares M, Uauy R, Araya M. Risks and benefits of copper in light of new insights of copper homeostasis. J Trace Elem Med Biol. 2011;25(1):3–13. doi:10.1016/j.jtemb.2010.11.004
   PubMed Web of Science ®Google Scholar
• Bartee MY, Lutsenko S. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level. Biometals. 2007;20(3–4):627–637. doi:10.1007/s10534-006-9074-3
   PubMed Web of Science ®Google Scholar
• De Filippis V, Vassiliev VB, Beltramini M, Fontana A, Salvato B, Gaitskhoki VS. Evidence for the molten globule state of human apo-ceruloplasmin. Biochim Biophys Acta. 1996;1297(2):119–123. doi:10.1016/S0167-4838(96)00139-2
   Web of Science ®Google Scholar
• Siotto M, Squitti R. Copper imbalance in Alzheimer’s disease: overview of the exchangeable copper component in plasma and the intriguing role albumin plays. Coord Chem Rev. 2018;371:86–95. doi:10.1016/j.ccr.2018.05.020
   Web of Science ®Google Scholar
• Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19(2):164–174.
   PubMed Web of Science ®Google Scholar
• Aigner E, Feldman A, Datz C. Obesity as an emerging risk factor for iron deficiency. Nutrients. 2014;6(9):3587–3600. doi:10.3390/nu6093587
   PubMed Web of Science ®Google Scholar
• Choi J, Masaratana P, Latunde-Dada GO, Arno M, Simpson RJ, McKie AT. Duodenal reductase activity and spleen iron stores are reduced and erythropoiesis is abnormal in Dcytb knockout mice exposed to hypoxic conditions. J Nutr. 2012;142(11):1929–1934. doi:10.3945/jn.112.160358
   Web of Science ®Google Scholar
• Chloupková M, Zhang AS, Enns CA. Stoichiometries of transferrin receptors 1 and 2 in human liver. Blood Cells Mol Dis. 2010;44(1):28–33. doi:10.1016/j.bcmd.2009.09.004
   Web of Science ®Google Scholar
• Anderson GJ, Frazer DM. Hepatic iron metabolism. Semin Liver Dis. 2005;25(4):420–432. doi:10.1055/s-2005-923314
   PubMed Web of Science ®Google Scholar
• De Domenico I, Ward DM, Di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26(12):2823–2831. doi:10.1038/sj.emboj.7601735
   PubMed Web of Science ®Google Scholar
• Musci G, Polticelli F, Bonaccorsi di Patti MC. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J Biol Chem. 2014;5(2):204–215. doi:10.4331/wjbc.v5.i2.204
   PubMedGoogle Scholar
• Tan MG, Kumarasinghe MP, Wang SM, Ooi LL, Aw SE, Hui KM. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med (Maywood). 2009;234(6):693–702. doi:10.3181/0807-RM-227
   PubMed Web of Science ®Google Scholar
• Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21(2):195–199. doi:10.1038/5979
   PubMed Web of Science ®Google Scholar
• Vasilyev VB. Looking for a partner: ceruloplasmin in protein-protein interactions. Biometals. 2019;32(2):195–210. doi:10.1007/s10534-019-00189-1
   PubMed Web of Science ®Google Scholar
• Altamura C, Squitti R, Pasqualetti P, et al. Ceruloplasmin/Transferrin system is related to clinical status in acute stroke. Stroke. 2009;40(4):1282–1288. doi:10.1161/STROKEAHA.108.536714
   Web of Science ®Google Scholar
• Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann N Y Acad Sci. 1982;389:368–379. doi:10.1111/j.1749-6632.1982.tb22150.x
   PubMed Web of Science ®Google Scholar
• Ganini D, Canistro D, Jiang J, Stadler K, Mason RP, Kadiiska MB. Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection. Free Radic Biol Med. 2012;53(7):1514–1521. doi:10.1016/j.freeradbiomed.2012.07.013
   PubMed Web of Science ®Google Scholar
• Cerone SI, Sansinanea AS, Streitenberger SA, Garcia MC, Auza NJ. Cytochrome c oxidase, Cu, Zn-superoxide dismutase, and ceruloplasmin activities in copper-deficient bovines. Biol Trace Elem Res. 2000;73(3):269–278. doi:10.1385/BTER:73:3:269
   Web of Science ®Google Scholar
• Inoue K, Akaike T, Miyamoto Y, et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem. 1999;274(38):27069–27075. doi:10.1074/jbc.274.38.27069
   Web of Science ®Google Scholar
• Paradis M, Gagné J, Mateescu MA, Paquin J. The effects of nitric oxide-oxidase and putative glutathione-peroxidase activities of ceruloplasmin on the viability of cardiomyocytes exposed to hydrogen peroxide. Free Radic Biol Med. 2010;49(12):2019–2027. doi:10.1016/j.freeradbiomed.2010.09.030
   Web of Science ®Google Scholar
• Hellman NE, Kono S, Miyajima H, Gitlin JD. Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem. 2002;277(2):1375–1380. doi:10.1074/jbc.M109123200
   Web of Science ®Google Scholar
• Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res. 2006;39(1):15–23. doi:10.4067/S0716-97602006000100003
   Web of Science ®Google Scholar
• Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology. 2001;57(12):2205–2210. doi:10.1212/WNL.57.12.2205
   Web of Science ®Google Scholar
• Borges MD, de Albuquerque DM, Lanaro C, Costa FF, Fertrin KY. Clinical relevance of heterozygosis for aceruloplasminemia. Am J Med Genet B Neuropsychiatr Genet. 2019;180(4):266–271. doi:10.1002/ajmg.b.32723
   Web of Science ®Google Scholar
• Corradini E, Buzzetti E, Dongiovanni P, et al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. J Hepatol. 2021;75(3):506–513. doi:10.1016/j.jhep.2021.03.014
   PubMed Web of Science ®Google Scholar
• Pelucchi S, Ravasi G, Piperno A. Ceruloplasmin variants might have different effects in different iron overload disorders. J Hepatol. 2021;75(4):1003–1004. doi:10.1016/j.jhep.2021.05.005
   Web of Science ®Google Scholar
• Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of Type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. doi:10.3390/ijms21176275
   PubMed Web of Science ®Google Scholar
• Society CD. Guidelines for the prevention and control of type 2 diabetes in China (2017). Chin J Pract Internal Med. 2018;38(04):292–344.
   Google Scholar
• Chacko SK, Cheluvappa R. Increased ceruloplasmin and fibrinogen in type 2 diabetes corresponds to decreased anti-oxidant activity in a preliminary tertiary South Indian hospital study. Exp Clin Endocrinol Diabetes. 2010;118(1):64–67. doi:10.1055/s-0029-1225647
   Web of Science ®Google Scholar
• Sarkar A, Dash S, Barik BK, et al. Copper and ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. Indian J Clin Biochem. 2010;25(1):74–76. doi:10.1007/s12291-010-0015-0
   Google Scholar
• Sharma VK, Tumbapo A, Pant V, et al. Ceruloplasmin, a potential marker for glycemic status and its relationship with lipid profile in Type II diabetes mellitus. Asian J Med Sci. 2018;9(2):13–18. doi:10.3126/ajms.v9i2.19003
   Google Scholar
• Rusticeanu M, Zimmer V, Schleithoff L, et al. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms. Clin Genet. 2014;85(3):300–301. doi:10.1111/cge.12145
   Web of Science ®Google Scholar
• Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41(10):1241–1248. doi:10.1007/s001250051058
   PubMed Web of Science ®Google Scholar
• Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15:51. doi:10.1186/s12933-016-0369-6
   PubMed Web of Science ®Google Scholar
• Fizelova M, Jauhiainen R, Kangas AJ, et al. Differential associations of inflammatory markers with insulin sensitivity and secretion: the Prospective METSIM Study. J Clin Endocrinol Metab. 2017;102(9):3600–3609. doi:10.1210/jc.2017-01057
   Web of Science ®Google Scholar
• Grossmann V, Schmitt VH, Zeller T, et al. Profile of the immune and inflammatory response in individuals with prediabetes and Type 2 diabetes. Diabetes Care. 2015;38(7):1356–1364. doi:10.2337/dc14-3008
   PubMed Web of Science ®Google Scholar
• Everett BM, Donath MY, Pradhan AD, et al. Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes. J Am Coll Cardiol. 2018;71(21):2392–2401. doi:10.1016/j.jacc.2018.03.002
   PubMed Web of Science ®Google Scholar
• Tenenbaum A, Fisman EZ. Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner? Cardiovasc Diabetol. 2017;16(1):91. doi:10.1186/s12933-017-0573-z
   Web of Science ®Google Scholar
• Stienstra R, Joosten LA, Koenen T, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010;12(6):593–605. doi:10.1016/j.cmet.2010.11.011
   PubMed Web of Science ®Google Scholar
• Sokolov AV, Zakharova ET, Kostevich VA, Samygina VR, Vasilyev VB. Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes. Biometals. 2014;27(5):815–828. doi:10.1007/s10534-014-9755-2
   PubMed Web of Science ®Google Scholar
• Fardoun RZ. The use of vitamin E in type 2 diabetes mellitus. Clin Exp Hypertens. 2007;29(3):135–148. doi:10.1080/10641960701361601
   PubMed Web of Science ®Google Scholar
• Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer’s disease. J Alzheimers Dis. 2009;16(4):763–774. doi:10.3233/JAD-2009-1013
   PubMed Web of Science ®Google Scholar
• Hernández-Beltrán N, Moreno CB, Gutiérrez-Álvarez AM. Contribution of mitochondria to pain in diabetic neuropathy. Endocrinol Nutr. 2013;60(1):25–32. doi:10.1016/j.endonu.2012.03.005
   Google Scholar
• Souza BM, Assmann TS, Kliemann LM, Gross JL, Canani LH, Crispim D. The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications. Arq Bras Endocrinol Metabol. 2011;55(4):239–248. doi:10.1590/S0004-27302011000400001
   Google Scholar
• Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, Maulik G. Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease–an overview. Toxicol Mech Methods. 2012;22(5):330–335. doi:10.3109/15376516.2012.666648
   PubMed Web of Science ®Google Scholar
• Islam KN, Takahashi M, Higashiyama S, Myint T, Uozumi N. Fragmentation of ceruloplasmin following non-enzymatic glycation reaction. J Biochem. 1995;118(5):1054–1060. doi:10.1093/jb/118.5.1054
   Web of Science ®Google Scholar
• Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY. Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits. Diabetologia. 2002;45(9):1325–1331. doi:10.1007/s00125-002-0888-4
   Web of Science ®Google Scholar
• Jeppu AK, Kumar KA, Augusthy A. Plasma glucose and serum ceruloplasmin in metabolic syndrome and diabetes mellitus type 2. Recent Adv Biol Med. 2016;2(2016):651.
   Google Scholar
• Srivatsan R, Das S, Gadde R, et al. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med. 2009;12(2):121–127.
   Web of Science ®Google Scholar
• Li M, Fang F. Related analysis on type 2 diabetes and trace elements. Guangdong Trace Elements Sci. 2012;19(3):1–4.
   Google Scholar
• Sanjeevi N, Freeland-Graves J, Beretvas SN, Sachdev PK. Trace element status in type 2 diabetes: a meta-analysis. J Clin Diagn Res. 2018;12(5):Oe01–oe08. doi:10.7860/JCDR/2018/35026.11541
   Web of Science ®Google Scholar
• Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem. 2009;16(1):113–129. doi:10.2174/092986709787002862
   Web of Science ®Google Scholar
• Lee EC, Ha E, Singh S, et al. Copper (II)-human amylin complex protects pancreatic cells from amylin toxicity. Phys Chem Chem Phys. 2013;15(30):12558–12571. doi:10.1039/c3cp44542a
   Web of Science ®Google Scholar
• Lei Y. Effect of Green Tea Polyphenols on Glucose Homeostasis and Its Mechanism in Ceruloplasmin Gene Knockout Mice. Hebei Medical University; 2017.
   Google Scholar
• Arredondo M, Fuentes M, Jorquera D, et al. Cross-talk between body iron stores and diabetes: iron stores are associated with activity and microsatellite polymorphism of the heme oxygenase and type 2 diabetes. Biol Trace Elem Res. 2011;143(2):625–636. doi:10.1007/s12011-010-8895-7
   Web of Science ®Google Scholar
• Bonaccorsi di Patti MC, Cutone A, Polticelli F, et al. The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin. Biometals. 2018;31(3):399–414. doi:10.1007/s10534-018-0087-5
   PubMed Web of Science ®Google Scholar
• Lee MJ, Jung CH, Kang YM, et al. Serum ceruloplasmin level as a predictor for the progression of diabetic nephropathy in Korean men with Type 2 diabetes mellitus. Diabetes Metab J. 2015;39(3):230–239. doi:10.4093/dmj.2015.39.3.230
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013;124(3):139–152. doi:10.1042/CS20120198
   PubMed Web of Science ®Google Scholar
• Cooper GJ, Young AA, Gamble GD, et al. A copper (II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia. 2009;52(4):715–722. doi:10.1007/s00125-009-1265-3
   Web of Science ®Google Scholar
• Adki KM, Kulkarni YA. Potential biomarkers in diabetic retinopathy. Curr Diabetes Rev. 2020;16(9):971–983. doi:10.2174/1573399816666200217092022
   Web of Science ®Google Scholar
• Chu J, Gao R, Zhao S, Lu G, Zhao D, Li J. 2016 Chinese guideline for the management of dyslipidemia in adults. Chin Circ J. 2016;31(10):937–953.
   Google Scholar
• Li W, Zhou C. Advances in studies on hyperlipidemia, atherosclerosis and lipid metabolism. Chin J Pharmacol Toxicol. 2019;33(10):811.
   Google Scholar
• Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Familial hypercholesterolaemia. Nat Rev Dis Primers. 2017;3:17093. doi:10.1038/nrdp.2017.93
   PubMed Web of Science ®Google Scholar
• Rygiel K. Hypertriglyceridemia - common causes, prevention and treatment strategies. Curr Cardiol Rev. 2018;14(1):67–76. doi:10.2174/1573403X14666180123165542
   Web of Science ®Google Scholar
• Li T, Jiang S, Lu C, et al. Snapshots: endoplasmic reticulum stress in lipid metabolism and cardiovascular disease. Curr Issues Mol Biol. 2018;28:14–28. doi:10.21775/cimb.028.014
   Web of Science ®Google Scholar
• Cao SS, Luo KL, Shi L. Endoplasmic reticulum stress interacts with inflammation in human diseases. J Cell Physiol. 2016;231(2):288–294. doi:10.1002/jcp.25098
   PubMed Web of Science ®Google Scholar
• Sozen E, Ozer NK. Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: an updated mini-review. Redox Biol. 2017;12:456–461. doi:10.1016/j.redox.2017.02.025
   PubMed Web of Science ®Google Scholar
• Lee SY, Hong IK, Kim BR, et al. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. Hepatology. 2015;62(1):135–146. doi:10.1002/hep.27804
   PubMed Web of Science ®Google Scholar
• Zhou W, Shen X, Wang L, Zhang Q, Lu Y. Influences of fenofibrate on oxidative stress and endoplasmic reticulum stress in livers of hyperlipidemic rats. J Pract Med. 2014;30(17):2718–2721.
   Google Scholar
• Oe S, Miyagawa K, Honma Y, Harada M. Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson disease. Exp Cell Res. 2016;347(1):192–200. doi:10.1016/j.yexcr.2016.08.003
   Web of Science ®Google Scholar
• Kono S, Suzuki H, Oda T, et al. Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia. Neuromolecular Med. 2006;8(3):361–374. doi:10.1385/NMM:8:3:361
   Web of Science ®Google Scholar
• Shen Z. Correlation among blood lipids and main inflammatory factors levels in patients with coronary heart disease complicated hyperlipidemia. Chin J Cardiovasc Rehabil Med. 2017;26(4):388–390.
   Google Scholar
• Chen S. Interconnectivity Between the Reaction System of Catalase and Hyperlipidemia. Jilin University; 2013.
   Google Scholar
• Anila L, Vijayalakshmi N. Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chem. 2003;83(4):569–574. doi:10.1016/S0308-8146(03)00155-9
   Web of Science ®Google Scholar
• Zhang L, Liu X, Liang W, Zhong C. Study on oxidative stress level in patients with hyperlipidemia. Studies Trace Elements Health. 2016;33(01):9–10.
   Google Scholar
• Samokyszyn VM, Miller DM, Reif DW, Aust SD. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem. 1989;264(1):21–26. doi:10.1016/S0021-9258(17)31218-8
   PubMed Web of Science ®Google Scholar
• Shukla N, Maher J, Masters J, Angelini GD, Jeremy JY. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis. 2006;187(2):238–250. doi:10.1016/j.atherosclerosis.2005.11.035
   PubMed Web of Science ®Google Scholar
• Wang B, Wang XP. Does ceruloplasmin defend against neurodegenerative diseases? Curr Neuropharmacol. 2019;17(6):539–549. doi:10.2174/1570159X16666180508113025
   Web of Science ®Google Scholar
• Commission N. The report on nutrition and chronic diseases in China (2015) release. Shanghai J Prevent Med. 2016;28(3):141.
   Google Scholar
• Chen Y, Zhang Y, Kong Z, Yu J, Sun T, Zhang H. The prevalence of overweight and obesity in children and adolescents in China. Chin J Dis Control Prev. 2017;21(9):866–869, 878.
   Google Scholar
• Tajik N, Golpaie A, Keshavarz SA, et al. Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women. J Endocrinol Invest. 2012;35(6):566–569. doi:10.3275/7878
   Web of Science ®Google Scholar
• Moreno-Navarrete JM, Fernández-Real JM. The complement system is dysfunctional in metabolic disease: evidences in plasma and adipose tissue from obese and insulin resistant subjects. Semin Cell Dev Biol. 2019;85:164–172. doi:10.1016/j.semcdb.2017.10.025
   Web of Science ®Google Scholar
• Ziakas A, Gavrilidis S, Souliou E, et al. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina. Angiology. 2009;60(1):50–59. doi:10.1177/0003319708314249
   Web of Science ®Google Scholar
• Ruggiero C, Ehrenshaft M, Cleland E, Stadler K. High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab. 2011;300(6):E1047–1058. doi:10.1152/ajpendo.00666.2010
   Web of Science ®Google Scholar
• Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Susanna I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity. 2008;16(5):958–964. doi:10.1038/oby.2008.10
   Web of Science ®Google Scholar
• Guo Y, Chen P, Xiao W. Mitochondrial dysfunction and exercise regulation in adipose tissue during obesity. Chin J Biochem Mol Biol. 2020;36(10):1145–1150.
   Google Scholar
• Curtis JM, Grimsrud PA, Wright WS, et al. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes. 2010;59(5):1132–1142.
   PubMed Web of Science ®Google Scholar
• Yuan K, Lin N, Chen H. Relationship between intestinal flora and pathogenesis of obesity. Med Recapitulate. 2018;24(21):4166–4171.
   Google Scholar
• Barra NG, Anhê FF, Cavallari JF, Singh AM, Chan DY, Schertzer JD. Micronutrients impact the gut microbiota and blood glucose. J Endocrinol. 2021;250(2):R1–r21. doi:10.1530/JOE-21-0081
   PubMed Web of Science ®Google Scholar
• Mayneris-Perxachs J, Cardellini M, Hoyles L, et al. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome. 2021;9(1):104. doi:10.1186/s40168-021-01052-7
   PubMed Web of Science ®Google Scholar
• Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev. 2011;32(4):550–570. doi:10.1210/er.2010-0030
   PubMed Web of Science ®Google Scholar
• Lehr S, Hartwig S, Lamers D, et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics. 2012;11(1):M111.010504. doi:10.1074/mcp.M111.010504
   Web of Science ®Google Scholar
• Safavi SM, Ziaei R, Maracy MR. Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran. J Obes. 2012;2012:951093. doi:10.1155/2012/951093
   Google Scholar
• Göçmen AY, Sahin E, Semiz E, Gümuşlü S. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease? Can J Cardiol. 2008;24(3):209–212. doi:10.1016/S0828-282X(08)70586-5
   Web of Science ®Google Scholar
• Mori T, Sasaki J, Kawaguchi H, et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 1995;129(2):234–238. doi:10.1016/0002-8703(95)90003-9
   Web of Science ®Google Scholar
• Reunanen A, Knekt P, Aaran RK. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol. 1992;136(9):1082–1090. doi:10.1093/oxfordjournals.aje.a116573
   Web of Science ®Google Scholar
• Mänttäri M, Manninen V, Hurrunen JK, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J. 1994;15(12):1599–1603. doi:10.1093/oxfordjournals.eurheartj.a060440
   Web of Science ®Google Scholar
• Enbergs A, Dorszewski A, Luft M, et al. Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis. Coron Artery Dis. 1998;9(2–3):119–124.
   Web of Science ®Google Scholar
• Klipstein-Grobusch K, Grobbee DE, Koster JF, et al. Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study. Br J Nutr. 1999;81(2):139–144. doi:10.1017/S0007114599000276
   Web of Science ®Google Scholar
• Engström G, Stavenow L, Hedblad B, et al. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol. 2003;23(12):2247–2251. doi:10.1161/01.ATV.0000102924.11767.8D
   PubMed Web of Science ®Google Scholar
• Engström G, Hedblad B, Stavenow L, et al. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation. 2004;110(1):27–31. doi:10.1161/01.CIR.0000133277.88655.00
   Web of Science ®Google Scholar
• Verma VK, Ramesh V, Tewari S, Gupta RK, Sinha N, Pandey CM. Role of bilirubin, vitamin C and ceruloplasmin as antioxidants in coronary artery disease [CAD]. Indian J Clin Biochem. 2005;20(2):68–74. doi:10.1007/BF02867403
   Google Scholar
• Brunetti ND, Pellegrino PL, Correale M, De Gennaro L, Cuculo A, Di Biase M. Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction. J Thromb Thrombolysis. 2008;26(3):196–202. doi:10.1007/s11239-007-0088-7
   Web of Science ®Google Scholar
• Deepa M, Pasupathi P, Sankar KB, Rani P, Kumar SP. Free radicals and antioxidant status in acute myocardial infarction patients with and without diabetes mellitus. Bangladesh Med Res Counc Bull. 2009;35(3):95–100. doi:10.3329/bmrcb.v35i3.2999
   Google Scholar
• Kumar A, Nagtilak S, Sivakanesan R, Gunasekera S. Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients–a case controlled study from India. Southeast Asian J Trop Med Public Health. 2009;40(3):581–592.
   Web of Science ®Google Scholar
• Tang WH, Wu Y, Nicholls SJ, et al. Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation. Arterioscler Thromb Vasc Biol. 2010;30(3):634–640. doi:10.1161/ATVBAHA.109.201210
   Web of Science ®Google Scholar
• Tang WH, Wu Y, Hartiala J, et al. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32(2):516–522. doi:10.1161/ATVBAHA.111.237040
   Web of Science ®Google Scholar
• Xu Y, Lin H, Zhou Y, Cheng G, Xu G. Ceruloplasmin and the extent of heart failure in ischemic and nonischemic cardiomyopathy patients. Mediators Inflamm. 2013;2013:348145. doi:10.1155/2013/348145
   Web of Science ®Google Scholar
• Grammer TB, Kleber ME, Silbernagel G, et al. Copper, ceruloplasmin, and long-term cardiovascular and total mortality (the Ludwigshafen Risk and Cardiovascular Health Study). Free Radic Res. 2014;48(6):706–715. doi:10.3109/10715762.2014.901510
   PubMed Web of Science ®Google Scholar
• Daybanyrova LV, Shevchenko OP. Clinical significance levels of c-reactive protein and ceruloplasmin in patients with ischemic heart disease. Wiad Lek. 2015;68(4):517–519.
   Google Scholar
• Bao X, Borné Y, Johnson L, et al. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the “common soil” hypothesis. Cardiovasc Diabetol. 2018;17(1):87. doi:10.1186/s12933-018-0733-9
   Web of Science ®Google Scholar